Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Acute Bipolar Manic Episode”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 13 of 0 results

Testing effectiveness (Phase 2)Study completedNCT00374920
What this trial is testing

Safety and Efficacy of MEM 1003 Versus Placebo for the Treatment of Patients With Bipolar I Disorder

Who this might be right for
Bipolar Disorder With Manic or Mixed Episodes
Memory Pharmaceuticals 60
Large-scale testing (Phase 3)Active Not RecruitingNCT06608641
What this trial is testing

Efficacy and Safety of Endoxifen in Bipolar I Disorder Patients

Who this might be right for
Bipolar 1 Disorder
Jina Pharmaceuticals Inc. 490
Large-scale testing (Phase 3)Study completedNCT00145509
What this trial is testing

40 Week Trial to Study the Safety of Asenapine When Added to Lithium or Valproate in the Treatment of Bipolar Disorder (A7501009)(P05786)

Who this might be right for
Bipolar Disorder
Organon and Co 77
Large-scale testing (Phase 3)Study completedNCT00035230
What this trial is testing

A Study on the Safety and Efficacy of Topiramate in the Treatment of Patients With Bipolar I Disorder

Who this might be right for
Bipolar Disorder
Johnson & Johnson Pharmaceutical Research & Development, L.L.C. 338
Large-scale testing (Phase 3)Study completedNCT00240721
What this trial is testing

The Effectiveness and Safety of Topiramate in the Treatment of Patients With Bipolar Disorder

Who this might be right for
Bipolar DisordersMood DisordersAffective Disorders, Psychotic
Johnson & Johnson Pharmaceutical Research & Development, L.L.C. 363
Not applicableStudy completedNCT01239589
What this trial is testing

European Study to Describe Hospital Stay in Patients Admitted for Acute Bipolar Manic Episodes

Who this might be right for
Acute Bipolar Manic Episode
AstraZeneca 1,280
Testing effectiveness (Phase 2)Active Not RecruitingNCT07046494
What this trial is testing

Study Evaluating the Efficacy and Safety of RAP-219 in Adult Participants With Bipolar I Disorder

Who this might be right for
Bipolar 1 Disorder
Rapport Therapeutics Inc. 253
Large-scale testing (Phase 3)Study completedNCT00159796
What this trial is testing

3-week Study of Asenapine, Olanzapine and Placebo for Treatment of Bipolar Mania (P07009)

Who this might be right for
Bipolar Disorder
Organon and Co 489
Large-scale testing (Phase 3)Study completedNCT06462586
What this trial is testing

Study of Lumateperone in the Acute Treatment of Patients With Bipolar Mania

Who this might be right for
Bipolar Disorder, Manic
Intra-Cellular Therapies, Inc. 354
Large-scale testing (Phase 3)Study completedNCT01396291
What this trial is testing

Efficacy and Safety of Asenapine in the Prevention of Recurrence of Mood Episodes in Participants With Bipolar 1 Disorder (P06384)

Who this might be right for
Bipolar 1 Disorder
Forest Laboratories 561
Post-approval studies (Phase 4)Study completedNCT00397020
What this trial is testing

Naturalistic Study, Comparison of Divalproex Extended Release (ER) and Quetiapine for Adults With Acute Mania or Mixed Episodes

Who this might be right for
Bipolar Disorder
University of California, San Diego 30
Large-scale testing (Phase 3)Study completedNCT01977300
What this trial is testing

Atypical Antipsychotics for Continuation and Maintenance Treatment After an Acute Manic Episode

Who this might be right for
Bipolar I Disorder
University of British Columbia 159
Testing effectiveness (Phase 2)Ended earlyNCT01824602
What this trial is testing

Efficacy and Safety of Eslicarbazepine Acetate (BIA 2-093) in Acute Manic Episodes Associated With Bipolar I Disorder

Who this might be right for
BIPOLAR I DISORDER
Bial - Portela C S.A. 38